Postacute Sequelae of COVID-19 in Pediatric Patients Within the United States

COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients

Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome

Neurologic manifestations of COVID-19 and viral test in cerebrospinal fluid

Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin

Two-years mothering into the pandemic – Impact of the three COVID-19 waves in the Argentinian postpartum women’s mental health

First-Episode Psychosis incidence pre-, during, and post-COVID-19 pandemic

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY)

The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic

Modulation of RAAS receptors and miRNAs in COVID-19

Efficacy of monocyte distribution width in predicting critical illness in patients with COVID-19 pneumonia

Early biomarkers in hospitalized patients as predictors of post-acute sequelae of SARS-CoV-2 infection

Modulation of RAAS receptors and miRNAs in COVID-19

The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19

Neurocognitive and emotional long-term effects of COVID-19 infections in children and adolescents-Germany

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study – ScienceDirect

COVID-19 and neuropathy in type 2 diabetes

Direct and indirect impacts of the COVID-19 on life expectancy and person-years of life lost with or without disability

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19

ABO blood group and COVID-19 severity

Divergent psychological stress response patterns to the COVID-19 pandemic in psychiatric patients with vs. without PTSD

Disability-adjusted life years associated with COVID-19 in Brazil, 2020

Serum sST2 – key biomarkers in COVID-19 patients with implications for coronary artery disease

Cardiac symptoms in patients 3–6 months after contracting COVID-19

Long-term infectious sequelae after SARS-CoV-2 infection should be considered in mild cases too

Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA